Advisory Services Network’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,190
Closed -$130K 3986
2023
Q1
$130K Hold
1,190
﹤0.01% 1509
2022
Q4
$135K Buy
+1,190
New +$98.8K ﹤0.01% 1462
2021
Q3
Sell
-1,150
Closed -$108K 3665
2021
Q2
$108K Buy
+1,150
New +$106K ﹤0.01% 1570
2021
Q1
Sell
-1,150
Closed -$84K 3348
2020
Q4
$84K Sell
1,150
-8,415
-88% -$625K ﹤0.01% 1410
2020
Q3
$743K Buy
+9,565
New +$658K 0.04% 497
2020
Q2
Sell
-1,189
Closed -$35K 3132
2020
Q1
$35K Hold
1,189
﹤0.01% 1561
2019
Q4
$43K Sell
1,189
-2,280
-66% -$69.9K ﹤0.01% 1578
2019
Q3
$83K Hold
3,469
0.01% 1144
2019
Q2
$83K Buy
3,469
+3,180
+1,100% +$80.7K 0.01% 1142
2019
Q1
$8K Sell
289
-41
-12% -$972 ﹤0.01% 1958
2018
Q4
$7K Sell
330
-13
-4% -$255 ﹤0.01% 1934
2018
Q3
$7K Buy
343
+54
+19% +$1.03K ﹤0.01% 1962
2018
Q2
$5K Hold
289
﹤0.01% 2066
2018
Q1
$4K Hold
289
﹤0.01% 2249
2017
Q4
$4K Hold
289
﹤0.01% 2238
2017
Q3
$4K Hold
289
﹤0.01% 2014
2017
Q2
$3K Hold
289
﹤0.01% 2057
2017
Q1
$4K Buy
+289
New +$4.68K ﹤0.01% 1844
2016
Q2
Sell
-205
Closed -$3K 1992
2016
Q1
$3K Hold
205
﹤0.01% 1434
2015
Q4
$4K Hold
205
﹤0.01% 1225
2015
Q3
$4K Sell
205
-2,629
-93% -$83.1K ﹤0.01% 1217
2015
Q2
$98K Sell
2,834
-855
-23% -$26.1K 0.03% 384
2015
Q1
$94K Buy
3,689
+3,404
+1,194% +$62.4K 0.03% 397
2014
Q4
$4K Buy
+285
New +$3.57K ﹤0.01% 991

Other funds holding HZNP

Advisory Services Network's HZNP Position: Q2 2023 in Review

Advisory Services Network sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 1,190 shares — an estimated $130K sold.

Advisory Services Network first reported a position in HZNP in Q4 2014 and held it in 24 quarters. The position peaked at $743K in Q3 2020. 517 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

  • Advisory Services Network reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Advisory Services Network sold 1,190 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $130K.
  • Advisory Services Network first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014 and held it in 24 quarters.
  • Advisory Services Network's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $743K in Q3 2020.
  • 517 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Advisory Services Network's 13F filing for Q2 2023, filed 9 Aug 2023.